Latest News about MASI
Recent news which mentions MASI
The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback
March 22, 2019
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems
February 28, 2019
From Benzinga
Masimo Delivers Solid Q4 Growth and Boosts Its 2019 Outlook
February 27, 2019
Tickers
MASI
From Motley Fool
Masimo (MASI) Q4 2018 Earnings Conference Call Transcript
February 26, 2019
Tickers
MASI
From Motley Fool
The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote
February 25, 2019
From Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
February 22, 2019
From Benzinga
The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering
February 12, 2019
From Benzinga
3 Healthcare Stocks Still Raising Expectations
January 14, 2019
From Motley Fool
Benzinga's Top Upgrades, Downgrades For December 19, 2018
December 19, 2018
From Benzinga
Tickers
MASI
From Motley Fool
Masimo Corp (MASI) Q3 2018 Earnings Conference Call Transcript
October 31, 2018
Tickers
MASI
From Motley Fool
1 Extraordinary Investor, Plus a 5-Stock Sampler Annual Check-In
October 29, 2018
From Motley Fool
From MarketWatch
The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares
October 03, 2018
From Benzinga
10 Biggest Price Target Changes For Tuesday
October 02, 2018
From Benzinga
The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut
September 14, 2018
From Benzinga
Reviewing the Original Rule Breakers 5-Stock Sampler, and Offering a New One
September 11, 2018
From Motley Fool
The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results
September 05, 2018
From Benzinga
The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero
August 23, 2018
From Benzinga
The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin
August 22, 2018
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows
August 21, 2018
From Benzinga
The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns
August 17, 2018
From Benzinga
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue
August 15, 2018
From Benzinga
The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings
August 03, 2018
From Benzinga
Tickers
MASI
From Motley Fool
The 6 Stocks on the MFM Team's Radar This Week
June 19, 2018
From Motley Fool
Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time
May 31, 2018
From Benzinga
3 Top Healthcare Stocks to Buy in May
May 14, 2018
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.